focus -WSS

focus

author：entertainment 2025-09-27 18:22:25 - browse：363

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Adopting new red light myopia treatments may be short

WSS

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Gene therapy for Afghan refugees’ infant will be fully covered

Roche drug slashes death risk in early

Bernie brings in new pharma CEOs to talk drug prices

Smaller biotechs seek to piggyback on weight loss drug boom

STAT Summit: How researchers deal with rejection

entertainment

focus

entertainment

Psychedelics group wrestles with new pharma identity

How AI can help patients find reliable information about doctors

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why a market frenzy over new weight loss drugs defies logic

Affirmative action in medical school literally saved lives

FDA clears Verve to begin U.S. study of gene

Anesthesiologist group: stop taking Ozempic before surgery

UnitedHealth, Optum discontinue NaviHealth name

United colonoscopy coverage change 'may cost lives,' doctors say

A protest over insulin prices is seen as a fight for life

hotspot

STAT Readout: Friday, Oct. 20 biotech updates

Texas Medical Board asked to define abortion emergency exception

Problems with a popular proposal to regulate AI in health care

The Biogen Aduhelm mess could happen again

Devoted Health’s losses in Medicare Advantage persist

The Biogen Aduhelm mess could happen again

hotspot

knowledge

entertainment

explore